Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

April 30, 2004

Conditions
Atopic DermatitisEczema
Interventions
DRUG

Nanocrystalline silver cream (NPI)

Trial Locations (19)

10021

Sadick Dermatology & Aesthetic Surgery, New York

10029

Mount Sinai School of Medicine, New York

19115

Radiant Research, Philadelphia

20037

nTouch Research, Washington D.C.

27103

Clinical Research of Winston-Salem, Inc., Winston-Salem

29407

National Allergy, Asthma & Urticaria Centers of Charleston, P.A., Charleston

29605

Radiant Research, Greer

33407

Radiant Research, West Palm Beach

35209

Radiant Research, Birmingham

35801

Medical Affliated Research Centers, Inc., Huntsville

37203

ACE Research Specialists, Inc., Nashville

43212

Radiant Research, Columbus

44106

University Hospitals of Cleveland, Cleveland

63141

Radiant Research, St Louis

66215

Radiant Research, Overland Park

80206

National Jewish Medical & Research Center, Denver

83704

Radiant Research, Boise

97239

Oregon Health & Science University, Portland

98499

Radiant Research, Lakewood

Sponsors
All Listed Sponsors
lead

Nucryst Pharmaceuticals

INDUSTRY